Amedica Corporation (NASDAQ: AMDA) is having a great day in the market today, and for good reason. The comapny announced that a key asset sale has closed, bringing important funds through the door. Of course, the news excited investors who are pushing the stock on a run for the top. Today, we’ll talk about: The … Read more
Amedica Corporation (NASDAQ: AMDA) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into an agreement to sell an asset. As you could imagine, the news excited investors, sending the stock screaming for the top. Today, we’ll talk about: The asset … Read more
Amedica Corporation (NASDAQ: AMDA) is having an overwhelmingly strong start to the trading session this morning, following up on the tremendous gains the stock saw yesterday. The gains are ultimately the result of the company’s announcement of its first successful spine fusion surgery. Of course, the news excited investors, which is continuing to send the … Read more
Amedica Corporation (NASDAQ: AMDA) is having an overwhelmingly strong day in the market today, gaining in multiples after providing a clinical update. Of course, the update was positive, leading to excitement among investors. Today, we’ll talk about: The update; what we’re seeing from AMDA; and what we’ll be watching for ahead. AMDA Heads For The … Read more
Amedica Corporation (NASDAQ: AMDA) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has received positive news from the FDA. Of course, this is leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the news, what … Read more
Amedica Corporation (NASDAQ: AMDA) Amedica Corporation is off to an incredible start to the trading session today. The stock started the day off well into the green and has had no problem at all with regard to holding onto its gains. Today, we’ll talk about what we’re seeing from the stock, why, and what we’ll … Read more